| Dr Thomas C Williams, MD | |
|
1808 W Main St, Russellville, AR 72801-2724 | |
| (479) 968-2841 | |
| Not Available |
| Full Name | Dr Thomas C Williams |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 34 Years |
| Location | 1808 W Main St, Russellville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790786408 | NPI | - | NPPES |
| 050031807 | Other | RR MEDICARE GROUP CC5970 | |
| 770078201 | Other | AR | AR BREASTCARE |
| 125265001 | Medicaid | AR | |
| 5J371 | Other | AR | BLUE CROSS BLUE SHIELD AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | C7989 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Marys Regional Medical Center | Russellville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Mary's Specialty, Llc | 5496189318 | 8 |
News Archive
New research from the University of California, San Diego Department of Medicine, Division of Nephrology, shows that the anti-rejection drug sirolimus (brand name Rapamune) may help prolong the clinical benefit of transplanted kidneys and delay rejection, especially in patients who do not regularly take their prescribed medications (are "non-compliant"). While the transplant field has been highly successful at reducing rejection and graft loss in the first year, post-transplant, reducing risk for graft rejection in the long-term has proved more difficult.
Microbes are often seen as pathogens that cause disease and antibiotics have been used successfully to combat these foreign invaders. In reality, the picture is more complex.
Conceptus, Inc., developer of the Essure procedure, the first proven non-surgical permanent birth control method available, today reported financial results for the three months ended June 30, 2010.
Genentech, a member of the Roche Group today announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil [5-FU]) for HER2-positive metastatic (cancer that has spread) cancer of the stomach or gastroesophageal junction, in men and women who have not received prior medicines for their metastatic disease.
› Verified 9 days ago
| Entity Name | St Mary's Specialty, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831730670 PECOS PAC ID: 5496189318 Enrollment ID: O20200102000443 |
News Archive
New research from the University of California, San Diego Department of Medicine, Division of Nephrology, shows that the anti-rejection drug sirolimus (brand name Rapamune) may help prolong the clinical benefit of transplanted kidneys and delay rejection, especially in patients who do not regularly take their prescribed medications (are "non-compliant"). While the transplant field has been highly successful at reducing rejection and graft loss in the first year, post-transplant, reducing risk for graft rejection in the long-term has proved more difficult.
Microbes are often seen as pathogens that cause disease and antibiotics have been used successfully to combat these foreign invaders. In reality, the picture is more complex.
Conceptus, Inc., developer of the Essure procedure, the first proven non-surgical permanent birth control method available, today reported financial results for the three months ended June 30, 2010.
Genentech, a member of the Roche Group today announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil [5-FU]) for HER2-positive metastatic (cancer that has spread) cancer of the stomach or gastroesophageal junction, in men and women who have not received prior medicines for their metastatic disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas C Williams, MD Po Box 1351, Russellville, AR 72811-1351 Ph: (800) 235-1415 | Dr Thomas C Williams, MD 1808 W Main St, Russellville, AR 72801-2724 Ph: (479) 968-2841 |
News Archive
New research from the University of California, San Diego Department of Medicine, Division of Nephrology, shows that the anti-rejection drug sirolimus (brand name Rapamune) may help prolong the clinical benefit of transplanted kidneys and delay rejection, especially in patients who do not regularly take their prescribed medications (are "non-compliant"). While the transplant field has been highly successful at reducing rejection and graft loss in the first year, post-transplant, reducing risk for graft rejection in the long-term has proved more difficult.
Microbes are often seen as pathogens that cause disease and antibiotics have been used successfully to combat these foreign invaders. In reality, the picture is more complex.
Conceptus, Inc., developer of the Essure procedure, the first proven non-surgical permanent birth control method available, today reported financial results for the three months ended June 30, 2010.
Genentech, a member of the Roche Group today announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil [5-FU]) for HER2-positive metastatic (cancer that has spread) cancer of the stomach or gastroesophageal junction, in men and women who have not received prior medicines for their metastatic disease.
› Verified 9 days ago
Dr. Ahmad Nadeem Rafi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1660 W C Pl, Russellville, AR 72801 Phone: 479-967-7770 Fax: 479-967-7772 | |
Dr. Stanley E. Gately, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1808 W Main St, Russellville, AR 72801 Phone: 479-968-2841 | |
Dr. Virgil R. Massey Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1808 W Main St, Russellville, AR 72801 Phone: 479-968-2841 |